Pylopass Lactobacillus reuteri: What It Is, Benefits, Dosage, and Sources

Pylopass Lactobacillus reuteri, often simply referred to as Pylopass, is a specific, patented strain of Lactobacillus reuteri bacteria, designated DSMZ 17648. Unlike many probiotics that aim to colonize the gut, Pylopass is primarily recognized for its unique ability to bind specifically to the bacterium Helicobacter pylori (H. Pylori) in the stomach. This binding mechanism is central to its proposed benefits, particularly in managing H. Pylori levels, which are associated with various gastrointestinal issues.

This article explains what Pylopass is, its reported benefits, common dosages, and how it differs from other Lactobacillus reuteri strains and probiotics.

H Pylori Control - with Pylopass™ - Lactobacillus Reuteri

The primary application for Pylopass revolves around its interaction with H. Pylori. H. Pylori is a common bacterium that can inhabit the stomach lining. While many people harbor H. Pylori without symptoms, for others, it can contribute to gastritis, peptic ulcers, and, in some cases, an increased risk of gastric cancer. Traditional approaches to managing H. Pylori often involve multi-drug antibiotic regimens, which can have side effects and contribute to antibiotic resistance.

Pylopass offers a different strategy. Instead of killing H. Pylori, it acts as a "molecular decoy." The cell walls of Pylopass contain specific adhesion molecules that recognize and bind to receptors on the surface of H. Pylori bacteria. Once bound, these H. Pylori cells are essentially "trapped" by the Pylopass bacteria. Because Pylopass itself is designed to pass through the digestive system without colonizing, it then carries the bound H. Pylori out of the body via the digestive tract. This mechanism aims to reduce the overall load of H. Pylori in the stomach without disrupting the broader gut microbiome or contributing to antibiotic resistance.

The practical implication here is that Pylopass doesn't eliminate H. Pylori entirely, but rather reduces its numbers. This reduction is thought to be sufficient to alleviate symptoms and reduce the risk of associated complications for some individuals. It's often considered as a complementary approach, either alongside conventional treatments or as a standalone option for those seeking a less aggressive intervention. However, it's not a direct substitute for medical treatment, especially in cases of active ulcers or severe H. Pylori-related disease.

Non-Viable Lactobacillus reuteri DSMZ 17648 (Pylopass)

A crucial aspect of Pylopass that sets it apart from many other probiotic supplements is its non-viable nature. Pylopass consists of inactivated, or "dead," Lactobacillus reuteri DSMZ 17648 cells. This might seem counterintuitive for a probiotic, as probiotics are typically defined as live microorganisms that confer a health benefit to the host. However, in the case of Pylopass, the cells do not need to be alive to exert their primary effect.

The specific binding mechanism relies on the structural components of the bacterial cell wall, which remain intact even when the cell is non-viable. This characteristic offers several practical advantages:

• Stability: Non-viable bacteria are generally more stable than live probiotics. They are less susceptible to degradation from stomach acid, bile salts, and changes in temperature or moisture during storage and transit. This can lead to a longer shelf life and more consistent product efficacy.
• Safety Profile: The risk of translocation (where bacteria move from the gut to other parts of the body) or systemic infection, which can be a theoretical concern with live probiotics in immunocompromised individuals, is essentially eliminated with non-viable cells.
• Targeted Action: Since Pylopass doesn't colonize, its action is primarily focused on binding H. Pylori and being excreted. This makes its role quite specific and less about broadly influencing the gut microbiome composition, though indirect effects are still possible.

This distinction is important when comparing Pylopass to other Lactobacillus reuteri strains. Many L. Reuteri strains are live probiotics known for various gut health benefits, immune modulation, and even oral health. Pylopass, while derived from L. Reuteri, functions through a different mechanism and with a more targeted goal due to its non-viable state and specific binding properties.

Study of Pylopass Versus Placebo in Subjects Who Are

Research into Pylopass has primarily focused on its efficacy in reducing H. Pylori load. Studies often compare Pylopass supplementation to a placebo group or to standard eradication therapy. The goal is to determine if Pylopass can significantly lower H. Pylori counts, and subsequently, impact symptoms or recurrence rates.

For instance, some clinical trials have investigated the reduction of H. Pylori measured by urea breath tests (UBT) or stool antigen tests after Pylopass intervention. These studies typically involve participants with confirmed H. Pylori infection. The findings generally suggest that Pylopass can lead to a significant reduction in H. Pylori colonization in a proportion of individuals. The extent of this reduction can vary, and it's often not a complete eradication, but rather a decrease in bacterial load.

One key aspect of these studies is understanding the context:

• Monotherapy vs. Adjunctive Therapy: Pylopass has been studied both as a standalone intervention (monotherapy) and as an add-on to standard antibiotic regimens. When used as an adjunct, it may help improve eradication rates or reduce side effects of antibiotics.
• Symptom Improvement: Beyond bacterial load, researchers also look at whether Pylopass can alleviate H. Pylori-related symptoms like indigestion, bloating, or abdominal discomfort. Symptom improvement doesn't always perfectly correlate with bacterial load reduction, as individual responses can vary.
• Long-term Effects: Like many dietary supplements, long-term studies on Pylopass are less common. Most research focuses on short-to-medium term outcomes (weeks to a few months).

It's important for individuals considering Pylopass to review the available research and discuss it with a healthcare professional. While promising, the results may not be universally applicable, and individual factors can influence outcomes.

Pylopass

Pylopass is a branded ingredient, developed and patented by J. Rettenmaier & Söhne (JRS Pharma). This means that when you see "Pylopass" on a supplement label, it refers specifically to the Lactobacillus reuteri DSMZ 17648 strain, manufactured and processed according to their specifications to ensure its non-viable state and H. Pylori-binding capabilities.

The branding helps distinguish this particular strain from other Lactobacillus reuteri strains, which may have different properties and intended uses. For example, other L. Reuteri strains like ATCC PTA 6475 or DSM 17938 are live probiotics often used for general gut health, infant colic, or immune support. Pylopass, by contrast, is specifically engineered for its H. Pylori-binding action.

When looking for supplements containing Pylopass, you will usually find it listed explicitly by its brand name and often with the strain designation DSMZ 17648. This ensures you are getting the specific ingredient intended for H. Pylori management rather than a general Lactobacillus reuteri probiotic.

Pylopass Benefits

The primary benefit associated with Pylopass is the reduction of H. Pylori load in the stomach. This can lead to several potential downstream benefits:

• Support for Gastric Comfort: By reducing H. Pylori numbers, Pylopass may help alleviate symptoms associated with H. Pylori infection, such as indigestion, bloating, and discomfort.
• Complementary to Eradication Therapy: For individuals undergoing antibiotic treatment for H. Pylori, Pylopass might be used as an adjunct to potentially improve eradication rates and mitigate some of the side effects of antibiotics on the gut microbiome.
• Reduced Risk of Recurrence: Some research suggests that maintaining lower H. Pylori levels could help reduce the risk of H. Pylori recurrence after successful eradication.
• Maintenance of Gut Health: While not a colonizing probiotic, by helping manage a potentially pathogenic bacterium, Pylopass contributes indirectly to a healthier gastric environment.

Pylopass Dosage

The typical recommended dosage for Pylopass in studies and commercial supplements is often around 200 mg per day. This amount usually delivers a substantial number of inactivated bacterial cells (often expressed as colony-forming units, or CFUs, even though they are non-viable, reflecting the initial count before inactivation).

It's usually advised to take Pylopass with water, often either before or after a meal, depending on the specific product instructions. Consistency is often emphasized for optimal results. The duration of supplementation can vary; some studies use it for 2-4 weeks, while others extend to several months. As with any supplement, it's best to follow the manufacturer's instructions or consult with a healthcare professional for personalized advice, especially if combining it with other medications.

Pylopass Side Effects

Pylopass is generally considered well-tolerated, with a low incidence of side effects reported in clinical studies. Because it is non-viable and does not colonize the gut, it avoids some of the potential issues associated with live probiotics, such as transient digestive upset (bloating, gas) as the microbiome adjusts.

Potential side effects, if any, are usually mild and may include:

• Mild Digestive Discomfort: Some individuals might experience minor stomach upset, although this is rare.
• Allergic Reactions: As with any food or supplement, there's a theoretical, albeit low, risk of an allergic reaction to components within the supplement.

Individuals with compromised immune systems or other serious medical conditions should always consult a healthcare provider before starting any new supplement, including Pylopass.

Pylopass Sources

Pylopass is not naturally found in foods. It is a proprietary ingredient manufactured for use in dietary supplements. Therefore, the only source of Pylopass is through supplements that specifically list "Pylopass" or "Lactobacillus reuteri DSMZ 17648" on their ingredient label.

You will typically find Pylopass in capsule or powder form, often as a standalone ingredient or sometimes combined with other gut-supportive compounds. When choosing a supplement, look for reputable brands that provide clear labeling and third-party testing where possible, to ensure product quality and purity.

Can PyloGuard (Pylopass) Help Manage Gut Dysbiosis

The concept of "gut dysbiosis" refers to an imbalance in the microbial community of the gut, where potentially harmful bacteria may outnumber beneficial ones, or overall diversity is reduced. While Pylopass's primary mechanism is specific to H. Pylori, its role in managing gut dysbiosis is more indirect.

By reducing the population of H. Pylori, Pylopass can contribute to a healthier balance within the stomach environment. H. Pylori itself can be considered a contributor to localized dysbiosis in the gastric mucosa. If its numbers are brought down, it might create a more favorable environment for beneficial bacteria or reduce inflammatory responses that can impact the broader gut microbiome.

However, Pylopass is not a broad-spectrum probiotic designed to repopulate the entire gut with diverse beneficial bacteria. Its action is highly targeted. Therefore, if the primary concern is widespread gut dysbiosis affecting the small or large intestine, a broader probiotic supplement containing various live strains known for colonization and diverse metabolic activities might be a more direct approach.

It's also worth noting that the stomach microbiome is distinct from the intestinal microbiome. While there's interaction, a healthy stomach environment (partially achieved by managing H. Pylori) can support overall digestive health, but Pylopass itself doesn't directly address imbalances in the lower gut.

A new approach in H Pylori control - Pylopass

Pylopass represents an newer "new approach" to H. Pylori management because it offers a non-antibiotic, non-colonizing method to reduce bacterial load. This contrasts sharply with the traditional triple or quadruple therapy involving multiple antibiotics and proton pump inhibitors.

The innovation lies in its specific molecular binding mechanism. Instead of relying on antimicrobial properties that can affect a wide range of bacteria (both good and bad) and contribute to resistance, Pylopass uses a physical adherence process. This makes it a gentler option that may be suitable for:

• Individuals who prefer natural or non-pharmacological options.
• Those who have failed antibiotic eradication therapy.
• People experiencing antibiotic side effects.
• Individuals with mild H. Pylori symptoms or lower bacterial loads.
• As a preventative measure against H. Pylori re-infection.

This table compares Pylopass with traditional antibiotic therapy for H. Pylori:

This comparison highlights why Pylopass is considered a "new approach"—it addresses a specific problem with a novel, targeted mechanism that aims to minimize the collateral damage often associated with broad-acting treatments.

FAQ

What is pylopass good for?

Pylopass is primarily good for reducing the load of Helicobacter pylori (H. Pylori) bacteria in the stomach. By binding to H. Pylori and facilitating its excretion, it can help alleviate symptoms associated with H. Pylori infection, such as indigestion and bloating. It can also be used as a complementary therapy alongside traditional antibiotic treatments for H. Pylori or as a preventative measure.

What food has the most L. Reuteri?

While various strains of Lactobacillus reuteri can be found in some fermented foods, Pylopass (L. Reuteri DSMZ 17648) itself is a specific, patented, non-viable strain and is not naturally present in foods. Other L. Reuteri strains are found in some fermented dairy products (like certain yogurts or kefirs), sourdough bread, and traditionally fermented meats. However, the concentration and specific strain properties in these foods would differ significantly from the Pylopass ingredient in supplements.

How long does it take for pylopass to work?

The time it takes for Pylopass to show effects can vary. Some studies have shown reductions in H. Pylori load after as little as 2-4 weeks of consistent supplementation. However, individual responses can differ based on initial H. Pylori load, overall health, and adherence to dosage. It's generally recommended to follow the specific product instructions and consult with a healthcare professional for guidance on duration.

Conclusion

Pylopass Lactobacillus reuteri (DSMZ 17648) offers a distinct, non-viable approach to managing Helicobacter pylori in the stomach. Its newer mechanism of binding to H. Pylori and facilitating its removal from the body differentiates it from traditional probiotics and antibiotic therapies. While not a cure for H. Pylori infection, Pylopass has shown promise in reducing bacterial load and supporting gastric comfort, making it a valuable option for those seeking complementary or alternative strategies. Individuals considering Pylopass should understand its specific role and consult with a healthcare provider to determine if it aligns with their health needs and goals.